A clinical evaluation of the XIENCE V everolimus eluting stent in the treatment of patients with coronary artery disease: Result from Thailand Registry – XIENCE V performance evaluation (THRIVE study)

OBJECTIVE: To evaluate the 2-year clinical outcomes of XIENCE(TM) V everolimus eluting stent (EES) for the treatment of coronary artery disease. BACKGROUND: Percutaneous coronary intervention with a drug eluting stent has become the preferred treatment in patients with coronary artery disease. Evero...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiatchoosakun, Songsak, Pienvichit, Pavit, Kuanprasert, Srun, Suraphakdee, Navin, Phromminikul, Arintaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414968/
https://www.ncbi.nlm.nih.gov/pubmed/28460763
http://dx.doi.org/10.1016/j.ihj.2016.10.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414968/
https://www.ncbi.nlm.nih.gov/pubmed/28460763
http://dx.doi.org/10.1016/j.ihj.2016.10.008

Ejemplares similares